

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.79730184 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.26366796 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.11974124 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.52585030 |
| 5 | glutamate secretion (GO:0014047) | 5.49866465 |
| 6 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.40247365 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 5.37891686 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.36871567 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.14937177 |
| 10 | vocalization behavior (GO:0071625) | 5.05664093 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.98575843 |
| 12 | regulation of synaptic vesicle transport (GO:1902803) | 4.69245940 |
| 13 | cellular potassium ion homeostasis (GO:0030007) | 4.68246119 |
| 14 | neurotransmitter secretion (GO:0007269) | 4.65442183 |
| 15 | sodium ion export (GO:0071436) | 4.65178611 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.64475816 |
| 17 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.51760039 |
| 18 | * neuronal action potential propagation (GO:0019227) | 4.48263851 |
| 19 | regulation of synapse structural plasticity (GO:0051823) | 4.40798321 |
| 20 | exploration behavior (GO:0035640) | 4.40179135 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.36570995 |
| 22 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.31254269 |
| 23 | layer formation in cerebral cortex (GO:0021819) | 4.08308239 |
| 24 | muscle filament sliding (GO:0030049) | 4.04318825 |
| 25 | actin-myosin filament sliding (GO:0033275) | 4.04318825 |
| 26 | protein localization to synapse (GO:0035418) | 4.04318087 |
| 27 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.01244796 |
| 28 | synaptic transmission, glutamatergic (GO:0035249) | 4.00083490 |
| 29 | gamma-aminobutyric acid transport (GO:0015812) | 3.99017196 |
| 30 | neuromuscular process controlling posture (GO:0050884) | 3.93448099 |
| 31 | long-term memory (GO:0007616) | 3.90591018 |
| 32 | regulation of synapse maturation (GO:0090128) | 3.88972165 |
| 33 | activation of protein kinase A activity (GO:0034199) | 3.85115777 |
| 34 | skeletal muscle contraction (GO:0003009) | 3.83370578 |
| 35 | creatine metabolic process (GO:0006600) | 3.79923253 |
| 36 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.78706440 |
| 37 | glutamate receptor signaling pathway (GO:0007215) | 3.78132589 |
| 38 | proline transport (GO:0015824) | 3.77847484 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.76397383 |
| 40 | neuromuscular process controlling balance (GO:0050885) | 3.75976523 |
| 41 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.75896830 |
| 42 | cell communication by electrical coupling (GO:0010644) | 3.70689466 |
| 43 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.67497996 |
| 44 | potassium ion import (GO:0010107) | 3.66681962 |
| 45 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.63623324 |
| 46 | glycine transport (GO:0015816) | 3.62979078 |
| 47 | neuron-neuron synaptic transmission (GO:0007270) | 3.62663156 |
| 48 | positive regulation of membrane potential (GO:0045838) | 3.62184116 |
| 49 | neurotransmitter transport (GO:0006836) | 3.60703162 |
| 50 | regulation of synaptic plasticity (GO:0048167) | 3.51000468 |
| 51 | regulation of skeletal muscle contraction (GO:0014819) | 3.47262337 |
| 52 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.47165314 |
| 53 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.45275406 |
| 54 | positive regulation of synapse maturation (GO:0090129) | 3.43913240 |
| 55 | regulation of neurotransmitter secretion (GO:0046928) | 3.41568185 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.41004779 |
| 57 | regulation of ARF protein signal transduction (GO:0032012) | 3.40709654 |
| 58 | positive regulation of dendritic spine development (GO:0060999) | 3.40583723 |
| 59 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.40079732 |
| 60 | regulation of postsynaptic membrane potential (GO:0060078) | 3.38885290 |
| 61 | * striated muscle contraction (GO:0006941) | 3.37788236 |
| 62 | L-amino acid import (GO:0043092) | 3.32615446 |
| 63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.32285208 |
| 64 | synaptic vesicle endocytosis (GO:0048488) | 3.31754223 |
| 65 | central nervous system myelination (GO:0022010) | 3.31220260 |
| 66 | axon ensheathment in central nervous system (GO:0032291) | 3.31220260 |
| 67 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.29594990 |
| 68 | amino acid import (GO:0043090) | 3.29586519 |
| 69 | regulation of relaxation of muscle (GO:1901077) | 3.25094680 |
| 70 | postsynaptic membrane organization (GO:0001941) | 3.24033711 |
| 71 | * membrane depolarization during action potential (GO:0086010) | 3.21123537 |
| 72 | neuromuscular synaptic transmission (GO:0007274) | 3.19433048 |
| 73 | cellular sodium ion homeostasis (GO:0006883) | 3.17680792 |
| 74 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.16887221 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16515016 |
| 76 | neurotransmitter uptake (GO:0001504) | 3.16175833 |
| 77 | * membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.15147038 |
| 78 | regulation of neurotransmitter transport (GO:0051588) | 3.14791636 |
| 79 | actin-mediated cell contraction (GO:0070252) | 3.12499666 |
| 80 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.09809070 |
| 81 | long-term synaptic potentiation (GO:0060291) | 3.09595074 |
| 82 | chemosensory behavior (GO:0007635) | 3.08492428 |
| 83 | neuron cell-cell adhesion (GO:0007158) | 3.08430680 |
| 84 | cerebellar granule cell differentiation (GO:0021707) | 3.08324914 |
| 85 | regulation of vesicle fusion (GO:0031338) | 3.07646011 |
| 86 | transmission of nerve impulse (GO:0019226) | 3.04756844 |
| 87 | * membrane depolarization (GO:0051899) | 3.04171843 |
| 88 | neuromuscular process (GO:0050905) | 3.03590602 |
| 89 | neuronal ion channel clustering (GO:0045161) | 3.02422154 |
| 90 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.00522527 |
| 91 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.00522527 |
| 92 | prepulse inhibition (GO:0060134) | 3.00255180 |
| 93 | potassium ion homeostasis (GO:0055075) | 3.00144691 |
| 94 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.98080791 |
| 95 | vesicle transport along microtubule (GO:0047496) | 2.97196448 |
| 96 | plasma membrane repair (GO:0001778) | 2.96796229 |
| 97 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.96574457 |
| 98 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.95087829 |
| 99 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.95087829 |
| 100 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.94792527 |
| 101 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.94784690 |
| 102 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.94091754 |
| 103 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.93517966 |
| 104 | skeletal muscle fiber development (GO:0048741) | 2.93434646 |
| 105 | dendritic spine organization (GO:0097061) | 2.92821655 |
| 106 | dendrite morphogenesis (GO:0048813) | 2.92702029 |
| 107 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.91140720 |
| 108 | response to auditory stimulus (GO:0010996) | 2.89183063 |
| 109 | * cardiac muscle contraction (GO:0060048) | 2.89181220 |
| 110 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.89070746 |
| 111 | regulation of synaptic transmission (GO:0050804) | 2.88439338 |
| 112 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.88004950 |
| 113 | vesicle docking involved in exocytosis (GO:0006904) | 2.86652415 |
| 114 | auditory behavior (GO:0031223) | 2.86563933 |
| 115 | positive regulation of neurotransmitter transport (GO:0051590) | 2.84620463 |
| 116 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.84528058 |
| 117 | cerebellar Purkinje cell layer development (GO:0021680) | 2.84197210 |
| 118 | membrane hyperpolarization (GO:0060081) | 2.83663249 |
| 119 | regulation of dendritic spine development (GO:0060998) | 2.83626744 |
| 120 | innervation (GO:0060384) | 2.83211542 |
| 121 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.83101554 |
| 122 | * synaptic transmission (GO:0007268) | 2.82425615 |
| 123 | regulation of cell communication by electrical coupling (GO:0010649) | 2.81743012 |
| 124 | detection of calcium ion (GO:0005513) | 2.81695886 |
| 125 | * regulation of ion transmembrane transporter activity (GO:0032412) | 2.81681407 |
| 126 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.81441363 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.53723508 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99241431 |
| 3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.96915128 |
| 4 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.93510491 |
| 5 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.90348296 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.90324847 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.83543916 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.83543916 |
| 9 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.67800028 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.65844602 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.62452516 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58046206 |
| 13 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.52132943 |
| 14 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.48285745 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.44355847 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42724851 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.36587682 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34315870 |
| 19 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.31466715 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.31062050 |
| 21 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.30293143 |
| 22 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.21451838 |
| 23 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.19809839 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.15883800 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.02697473 |
| 26 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.95385132 |
| 27 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.71669147 |
| 28 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.69300933 |
| 29 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.66539984 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.64740639 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.63492217 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.62927396 |
| 33 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.55235311 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.52535154 |
| 35 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.49028224 |
| 36 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.46563299 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.41812636 |
| 38 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.41481151 |
| 39 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.40070177 |
| 40 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.34004214 |
| 41 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31090890 |
| 42 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28379433 |
| 43 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25032105 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.24721064 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.24252838 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.24052263 |
| 47 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20090011 |
| 48 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19978310 |
| 49 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16520630 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16032154 |
| 51 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15717791 |
| 52 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.14916549 |
| 53 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13825748 |
| 54 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.13246544 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09062565 |
| 56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08406737 |
| 57 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.07865759 |
| 58 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07828078 |
| 59 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.07819217 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05390848 |
| 61 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05169194 |
| 62 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.03981334 |
| 63 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03687161 |
| 64 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03627610 |
| 65 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02043979 |
| 66 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.01532149 |
| 67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.01080910 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00899249 |
| 69 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.00098551 |
| 70 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.00025718 |
| 71 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.99586800 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99373411 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.96537421 |
| 74 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.96483461 |
| 75 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96450790 |
| 76 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.95907676 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95552412 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95334254 |
| 79 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95241749 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.94893624 |
| 81 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.94562446 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.94102247 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 0.92949876 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 0.92669266 |
| 85 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92381835 |
| 86 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91543328 |
| 87 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89170345 |
| 88 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.89057711 |
| 89 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88579205 |
| 90 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.88289424 |
| 91 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.88260701 |
| 92 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87894838 |
| 93 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.87838565 |
| 94 | STAT3_23295773_ChIP-Seq_U87_Human | 0.87102185 |
| 95 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.86938001 |
| 96 | SA1_27219007_Chip-Seq_Bcells_Human | 0.86823268 |
| 97 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.86026888 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85592323 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84635494 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84635494 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.84512347 |
| 102 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83993647 |
| 103 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.83682107 |
| 104 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.83266121 |
| 105 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.82268687 |
| 106 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.82203637 |
| 107 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.82203618 |
| 108 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81288171 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80880121 |
| 110 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.78919645 |
| 111 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.78859998 |
| 112 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78422472 |
| 113 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.77544911 |
| 114 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.76628170 |
| 115 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.76286013 |
| 116 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.75912599 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.75806426 |
| 118 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.75696007 |
| 119 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.75527880 |
| 120 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.75526215 |
| 121 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.74945722 |
| 122 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74449180 |
| 123 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74220499 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.72332214 |
| 125 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72272741 |
| 126 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71282628 |
| 127 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.70596995 |
| 128 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.69763168 |
| 129 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.68978717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.24826066 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 4.16742096 |
| 3 | MP0004270_analgesia | 3.92118612 |
| 4 | MP0003880_abnormal_central_pattern | 3.89637580 |
| 5 | MP0009046_muscle_twitch | 3.29015457 |
| 6 | MP0009745_abnormal_behavioral_response | 3.24533499 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.15748394 |
| 8 | * MP0002064_seizures | 3.05991187 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 2.90857281 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.70736562 |
| 11 | MP0002822_catalepsy | 2.56467679 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.54426417 |
| 13 | * MP0002272_abnormal_nervous_system | 2.51752674 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.47882084 |
| 15 | MP0000751_myopathy | 2.39735586 |
| 16 | MP0005423_abnormal_somatic_nervous | 2.38122320 |
| 17 | MP0001486_abnormal_startle_reflex | 2.35263857 |
| 18 | * MP0008569_lethality_at_weaning | 2.27150759 |
| 19 | MP0004858_abnormal_nervous_system | 2.19351918 |
| 20 | MP0001501_abnormal_sleep_pattern | 2.14236513 |
| 21 | MP0002736_abnormal_nociception_after | 2.08764025 |
| 22 | MP0003329_amyloid_beta_deposits | 2.03600319 |
| 23 | MP0002735_abnormal_chemical_nociception | 1.96078629 |
| 24 | MP0001440_abnormal_grooming_behavior | 1.95184893 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.88765353 |
| 26 | MP0002067_abnormal_sensory_capabilities | 1.87236395 |
| 27 | MP0002909_abnormal_adrenal_gland | 1.83576479 |
| 28 | MP0002733_abnormal_thermal_nociception | 1.82210323 |
| 29 | MP0003646_muscle_fatigue | 1.81204250 |
| 30 | MP0001970_abnormal_pain_threshold | 1.80819395 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.78739948 |
| 32 | MP0000749_muscle_degeneration | 1.65996583 |
| 33 | MP0002184_abnormal_innervation | 1.58639387 |
| 34 | MP0000747_muscle_weakness | 1.58072818 |
| 35 | MP0003879_abnormal_hair_cell | 1.55616107 |
| 36 | MP0000955_abnormal_spinal_cord | 1.54268816 |
| 37 | MP0003633_abnormal_nervous_system | 1.50857647 |
| 38 | MP0002557_abnormal_social/conspecific_i | 1.47123898 |
| 39 | MP0004885_abnormal_endolymph | 1.44381019 |
| 40 | MP0004924_abnormal_behavior | 1.44038561 |
| 41 | MP0005386_behavior/neurological_phenoty | 1.44038561 |
| 42 | * MP0002066_abnormal_motor_capabilities/c | 1.42404089 |
| 43 | MP0003075_altered_response_to | 1.38867065 |
| 44 | MP0004142_abnormal_muscle_tone | 1.33546064 |
| 45 | MP0004130_abnormal_muscle_cell | 1.26094396 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.24913383 |
| 47 | * MP0002882_abnormal_neuron_morphology | 1.23511370 |
| 48 | MP0004147_increased_porphyrin_level | 1.20279483 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.18912389 |
| 50 | MP0004036_abnormal_muscle_relaxation | 1.17403854 |
| 51 | MP0008961_abnormal_basal_metabolism | 1.15545748 |
| 52 | MP0005451_abnormal_body_composition | 1.14899140 |
| 53 | MP0004233_abnormal_muscle_weight | 1.14634655 |
| 54 | * MP0003631_nervous_system_phenotype | 1.14512010 |
| 55 | MP0000778_abnormal_nervous_system | 1.14238675 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.12914355 |
| 57 | MP0005646_abnormal_pituitary_gland | 1.09676634 |
| 58 | MP0003690_abnormal_glial_cell | 1.08289186 |
| 59 | MP0003123_paternal_imprinting | 1.06542162 |
| 60 | MP0002106_abnormal_muscle_physiology | 1.06540803 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.06258879 |
| 62 | MP0002269_muscular_atrophy | 1.04904080 |
| 63 | MP0001502_abnormal_circadian_rhythm | 1.03186748 |
| 64 | MP0003303_peritoneal_inflammation | 1.02978319 |
| 65 | MP0005167_abnormal_blood-brain_barrier | 1.02526513 |
| 66 | MP0005620_abnormal_muscle_contractility | 1.01791807 |
| 67 | MP0004215_abnormal_myocardial_fiber | 1.01492863 |
| 68 | MP0003283_abnormal_digestive_organ | 1.00834153 |
| 69 | MP0008874_decreased_physiological_sensi | 0.98664188 |
| 70 | MP0000920_abnormal_myelination | 0.98648718 |
| 71 | MP0000604_amyloidosis | 0.98478339 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 0.98232492 |
| 73 | MP0004087_abnormal_muscle_fiber | 0.97486383 |
| 74 | MP0000750_abnormal_muscle_regeneration | 0.96535731 |
| 75 | MP0004484_altered_response_of | 0.96520458 |
| 76 | MP0008872_abnormal_physiological_respon | 0.95980436 |
| 77 | MP0005623_abnormal_meninges_morphology | 0.94773043 |
| 78 | MP0004510_myositis | 0.94448454 |
| 79 | MP0005369_muscle_phenotype | 0.94118212 |
| 80 | MP0001984_abnormal_olfaction | 0.91412285 |
| 81 | MP0002152_abnormal_brain_morphology | 0.90847058 |
| 82 | MP0005535_abnormal_body_temperature | 0.89372400 |
| 83 | MP0006276_abnormal_autonomic_nervous | 0.88006994 |
| 84 | MP0002229_neurodegeneration | 0.87678763 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.85213457 |
| 86 | MP0003137_abnormal_impulse_conducting | 0.82655969 |
| 87 | MP0003787_abnormal_imprinting | 0.82275879 |
| 88 | MP0001177_atelectasis | 0.82272086 |
| 89 | MP0004085_abnormal_heartbeat | 0.81345277 |
| 90 | MP0003634_abnormal_glial_cell | 0.80071353 |
| 91 | MP0005330_cardiomyopathy | 0.76697555 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.75559240 |
| 93 | MP0004043_abnormal_pH_regulation | 0.74118855 |
| 94 | MP0001905_abnormal_dopamine_level | 0.73241128 |
| 95 | MP0005058_abnormal_lysosome_morphology | 0.72667346 |
| 96 | MP0001348_abnormal_lacrimal_gland | 0.71232978 |
| 97 | * MP0003632_abnormal_nervous_system | 0.69026993 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.67544051 |
| 99 | MP0005645_abnormal_hypothalamus_physiol | 0.66623768 |
| 100 | MP0005166_decreased_susceptibility_to | 0.66315484 |
| 101 | MP0001346_abnormal_lacrimal_gland | 0.65298097 |
| 102 | MP0005165_increased_susceptibility_to | 0.64879175 |
| 103 | MP0010234_abnormal_vibrissa_follicle | 0.63887053 |
| 104 | MP0002090_abnormal_vision | 0.63414033 |
| 105 | MP0003045_fibrosis | 0.63144129 |
| 106 | MP0000569_abnormal_digit_pigmentation | 0.63051196 |
| 107 | MP0003172_abnormal_lysosome_physiology | 0.61113804 |
| 108 | MP0002971_abnormal_brown_adipose | 0.58591081 |
| 109 | MP0004742_abnormal_vestibular_system | 0.57113432 |
| 110 | MP0001963_abnormal_hearing_physiology | 0.56151273 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.56029125 |
| 112 | MP0001485_abnormal_pinna_reflex | 0.54702521 |
| 113 | MP0002638_abnormal_pupillary_reflex | 0.53914664 |
| 114 | MP0002972_abnormal_cardiac_muscle | 0.53328685 |
| 115 | MP0000733_abnormal_muscle_development | 0.53122637 |
| 116 | MP0001943_abnormal_respiration | 0.51819177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.09345643 |
| 2 | Focal motor seizures (HP:0011153) | 6.65171227 |
| 3 | Visual hallucinations (HP:0002367) | 5.34104070 |
| 4 | Focal seizures (HP:0007359) | 5.10496010 |
| 5 | Action tremor (HP:0002345) | 4.83923861 |
| 6 | Exercise-induced myalgia (HP:0003738) | 4.37004014 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.23707060 |
| 8 | Muscle fiber splitting (HP:0003555) | 3.75921946 |
| 9 | Epileptic encephalopathy (HP:0200134) | 3.64190392 |
| 10 | Ankle clonus (HP:0011448) | 3.62233600 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 3.56554071 |
| 12 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.50661622 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.49807789 |
| 14 | Depression (HP:0000716) | 3.32954580 |
| 15 | Gaze-evoked nystagmus (HP:0000640) | 3.27844271 |
| 16 | Dysdiadochokinesis (HP:0002075) | 3.27554657 |
| 17 | Poor eye contact (HP:0000817) | 3.24979312 |
| 18 | Muscle fiber inclusion bodies (HP:0100299) | 3.22223782 |
| 19 | Dysmetria (HP:0001310) | 3.15675538 |
| 20 | Postural instability (HP:0002172) | 3.13691253 |
| 21 | Abnormality of the lower motor neuron (HP:0002366) | 3.13328778 |
| 22 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.10958056 |
| 23 | Myotonia (HP:0002486) | 3.10738912 |
| 24 | Broad-based gait (HP:0002136) | 3.10600503 |
| 25 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.05950952 |
| 26 | * Generalized tonic-clonic seizures (HP:0002069) | 3.04111060 |
| 27 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.01957847 |
| 28 | Urinary urgency (HP:0000012) | 3.00570758 |
| 29 | Abnormal social behavior (HP:0012433) | 2.99515835 |
| 30 | Impaired social interactions (HP:0000735) | 2.99515835 |
| 31 | Dysmetric saccades (HP:0000641) | 2.97057403 |
| 32 | Hemiplegia (HP:0002301) | 2.95625741 |
| 33 | Anxiety (HP:0000739) | 2.92660224 |
| 34 | Difficulty running (HP:0009046) | 2.92406036 |
| 35 | Annular pancreas (HP:0001734) | 2.90253379 |
| 36 | Intention tremor (HP:0002080) | 2.87010496 |
| 37 | Rhabdomyolysis (HP:0003201) | 2.86769717 |
| 38 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.85126269 |
| 39 | Obstructive sleep apnea (HP:0002870) | 2.77214145 |
| 40 | Nemaline bodies (HP:0003798) | 2.76274988 |
| 41 | Impaired smooth pursuit (HP:0007772) | 2.74972582 |
| 42 | Truncal ataxia (HP:0002078) | 2.73914549 |
| 43 | * Febrile seizures (HP:0002373) | 2.72619512 |
| 44 | EMG: neuropathic changes (HP:0003445) | 2.71829784 |
| 45 | Scanning speech (HP:0002168) | 2.71423751 |
| 46 | * Absence seizures (HP:0002121) | 2.69977563 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.65901121 |
| 48 | Neck muscle weakness (HP:0000467) | 2.64856846 |
| 49 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.61520105 |
| 50 | Subaortic stenosis (HP:0001682) | 2.61520105 |
| 51 | Type 1 muscle fiber predominance (HP:0003803) | 2.59848698 |
| 52 | Mutism (HP:0002300) | 2.59279324 |
| 53 | Abnormal eating behavior (HP:0100738) | 2.59086497 |
| 54 | Calf muscle hypertrophy (HP:0008981) | 2.58981733 |
| 55 | Genetic anticipation (HP:0003743) | 2.58932950 |
| 56 | Papilledema (HP:0001085) | 2.57605087 |
| 57 | Cerebral hypomyelination (HP:0006808) | 2.55833775 |
| 58 | Distal arthrogryposis (HP:0005684) | 2.53447958 |
| 59 | * Atonic seizures (HP:0010819) | 2.51024991 |
| 60 | Muscle stiffness (HP:0003552) | 2.49202618 |
| 61 | Achilles tendon contracture (HP:0001771) | 2.49029835 |
| 62 | Neuronal loss in central nervous system (HP:0002529) | 2.46958544 |
| 63 | Delusions (HP:0000746) | 2.46151797 |
| 64 | Ulnar deviation of the wrist (HP:0003049) | 2.45884053 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.45809341 |
| 66 | Asymmetric septal hypertrophy (HP:0001670) | 2.45460721 |
| 67 | * Dialeptic seizures (HP:0011146) | 2.44445694 |
| 68 | Amblyopia (HP:0000646) | 2.44415073 |
| 69 | Spastic gait (HP:0002064) | 2.43538969 |
| 70 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.40805726 |
| 71 | Myopathic facies (HP:0002058) | 2.38743837 |
| 72 | Torticollis (HP:0000473) | 2.38200925 |
| 73 | Impaired vibratory sensation (HP:0002495) | 2.35804116 |
| 74 | Focal dystonia (HP:0004373) | 2.30994580 |
| 75 | Rimmed vacuoles (HP:0003805) | 2.29721223 |
| 76 | Bradykinesia (HP:0002067) | 2.28587184 |
| 77 | Status epilepticus (HP:0002133) | 2.26457517 |
| 78 | EMG: myopathic abnormalities (HP:0003458) | 2.26244163 |
| 79 | Increased variability in muscle fiber diameter (HP:0003557) | 2.26175524 |
| 80 | Megalencephaly (HP:0001355) | 2.23906764 |
| 81 | Abnormality of the Achilles tendon (HP:0005109) | 2.23714653 |
| 82 | Diplopia (HP:0000651) | 2.23359198 |
| 83 | Abnormality of binocular vision (HP:0011514) | 2.23359198 |
| 84 | Hemiparesis (HP:0001269) | 2.23222592 |
| 85 | Distal lower limb amyotrophy (HP:0008944) | 2.22678505 |
| 86 | Foot dorsiflexor weakness (HP:0009027) | 2.21236356 |
| 87 | Abnormality of the foot musculature (HP:0001436) | 2.19259448 |
| 88 | Limb dystonia (HP:0002451) | 2.17225390 |
| 89 | Pointed chin (HP:0000307) | 2.15867323 |
| 90 | Stereotypic behavior (HP:0000733) | 2.15814148 |
| 91 | Hyporeflexia of lower limbs (HP:0002600) | 2.15637951 |
| 92 | Sudden death (HP:0001699) | 2.15456963 |
| 93 | Myoglobinuria (HP:0002913) | 2.14770093 |
| 94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.13995532 |
| 95 | Increased connective tissue (HP:0009025) | 2.12952010 |
| 96 | Akinesia (HP:0002304) | 2.12334064 |
| 97 | Rapidly progressive (HP:0003678) | 2.12237760 |
| 98 | Round ear (HP:0100830) | 2.11838207 |
| 99 | Lower limb muscle weakness (HP:0007340) | 2.10552400 |
| 100 | Areflexia of lower limbs (HP:0002522) | 2.09865369 |
| 101 | Resting tremor (HP:0002322) | 2.09307970 |
| 102 | Pheochromocytoma (HP:0002666) | 2.08808357 |
| 103 | Insomnia (HP:0100785) | 2.08217712 |
| 104 | Lower limb amyotrophy (HP:0007210) | 2.07841896 |
| 105 | Abnormality of the calf musculature (HP:0001430) | 2.04172080 |
| 106 | Abnormality of saccadic eye movements (HP:0000570) | 2.03388120 |
| 107 | Rigidity (HP:0002063) | 2.01168762 |
| 108 | Apathy (HP:0000741) | 2.01107926 |
| 109 | * Bundle branch block (HP:0011710) | 2.00231827 |
| 110 | Progressive inability to walk (HP:0002505) | 1.98725392 |
| 111 | Lower limb asymmetry (HP:0100559) | 1.97665538 |
| 112 | Craniofacial dystonia (HP:0012179) | 1.96383799 |
| 113 | Clonus (HP:0002169) | 1.96107108 |
| 114 | Tetraplegia (HP:0002445) | 1.95941157 |
| 115 | Insidious onset (HP:0003587) | 1.94677923 |
| 116 | Termporal pattern (HP:0011008) | 1.94677923 |
| 117 | Neurofibrillary tangles (HP:0002185) | 1.93400108 |
| 118 | Bulbar palsy (HP:0001283) | 1.93113654 |
| 119 | Gait ataxia (HP:0002066) | 1.92590362 |
| 120 | Spinal canal stenosis (HP:0003416) | 1.91792562 |
| 121 | Slow progression (HP:0003677) | 1.89938572 |
| 122 | Atrioventricular block (HP:0001678) | 1.89624067 |
| 123 | Shoulder girdle muscle weakness (HP:0003547) | 1.88160019 |
| 124 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.86171997 |
| 125 | Cerebral inclusion bodies (HP:0100314) | 1.86108525 |
| 126 | Spastic tetraparesis (HP:0001285) | 1.85610080 |
| 127 | Frequent falls (HP:0002359) | 1.84687874 |
| 128 | Difficulty climbing stairs (HP:0003551) | 1.84403852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.89347101 |
| 2 | MAP3K9 | 3.85632993 |
| 3 | EPHA4 | 3.67935075 |
| 4 | DAPK2 | 2.86981349 |
| 5 | PRKD3 | 2.74299346 |
| 6 | MINK1 | 2.62824581 |
| 7 | PAK6 | 2.61559659 |
| 8 | MAP3K4 | 2.45904251 |
| 9 | KSR2 | 2.45456003 |
| 10 | CAMKK1 | 2.42011496 |
| 11 | MAP2K4 | 2.09702580 |
| 12 | PHKG2 | 1.99634038 |
| 13 | PHKG1 | 1.99634038 |
| 14 | STK38 | 1.91680709 |
| 15 | NTRK1 | 1.85364057 |
| 16 | PINK1 | 1.77360387 |
| 17 | MAP2K7 | 1.73197741 |
| 18 | MARK1 | 1.72228517 |
| 19 | RIPK4 | 1.68903078 |
| 20 | NTRK2 | 1.62403851 |
| 21 | RIPK1 | 1.55903739 |
| 22 | CAMKK2 | 1.52812383 |
| 23 | CDK19 | 1.50150414 |
| 24 | CDK5 | 1.43397389 |
| 25 | MAP3K12 | 1.42253433 |
| 26 | DAPK1 | 1.39646698 |
| 27 | NEK1 | 1.39446013 |
| 28 | ARAF | 1.34155085 |
| 29 | TAOK1 | 1.33506558 |
| 30 | KSR1 | 1.30134386 |
| 31 | OBSCN | 1.29856307 |
| 32 | TYRO3 | 1.29750904 |
| 33 | GRK5 | 1.27016933 |
| 34 | MAP3K11 | 1.24947008 |
| 35 | MAP3K13 | 1.20632802 |
| 36 | LMTK2 | 1.19737893 |
| 37 | MAP3K2 | 1.19103463 |
| 38 | PRKCG | 1.17440651 |
| 39 | PRPF4B | 1.16351439 |
| 40 | PRKCH | 1.14029964 |
| 41 | CAMK1 | 1.10688516 |
| 42 | TRIB3 | 1.07588129 |
| 43 | MAP3K7 | 1.04944713 |
| 44 | UHMK1 | 1.04055630 |
| 45 | ALK | 1.01750921 |
| 46 | PKN1 | 1.00643913 |
| 47 | STK11 | 0.99885692 |
| 48 | LIMK1 | 0.99352355 |
| 49 | PLK2 | 0.99317386 |
| 50 | TAOK2 | 0.95606311 |
| 51 | RET | 0.94545396 |
| 52 | SIK2 | 0.93885096 |
| 53 | NME1 | 0.93587036 |
| 54 | WNK1 | 0.93153559 |
| 55 | LATS2 | 0.93119189 |
| 56 | PDK1 | 0.92883612 |
| 57 | FES | 0.91923962 |
| 58 | PDPK1 | 0.85425191 |
| 59 | MOS | 0.84915224 |
| 60 | CDK15 | 0.84794367 |
| 61 | TTN | 0.84203166 |
| 62 | CDK18 | 0.82908922 |
| 63 | SGK223 | 0.82807646 |
| 64 | SGK494 | 0.82807646 |
| 65 | MAP3K1 | 0.80590046 |
| 66 | SGK3 | 0.79635934 |
| 67 | DMPK | 0.78379462 |
| 68 | CDK14 | 0.77538080 |
| 69 | PTK2B | 0.75010973 |
| 70 | CDK11A | 0.73844221 |
| 71 | RAF1 | 0.73538901 |
| 72 | BMPR2 | 0.73139736 |
| 73 | MAP2K3 | 0.72704757 |
| 74 | MAPK13 | 0.72374577 |
| 75 | CAMK2A | 0.71412126 |
| 76 | TNK2 | 0.70529058 |
| 77 | PAK3 | 0.65329239 |
| 78 | MAPKAPK3 | 0.65295427 |
| 79 | TNIK | 0.65158333 |
| 80 | CAMK2G | 0.64317593 |
| 81 | SGK1 | 0.62879638 |
| 82 | SGK2 | 0.62475421 |
| 83 | CAMK4 | 0.62210995 |
| 84 | MUSK | 0.61243239 |
| 85 | BRAF | 0.59067264 |
| 86 | DAPK3 | 0.58138892 |
| 87 | PIK3CG | 0.57441834 |
| 88 | PNCK | 0.57195762 |
| 89 | SCYL2 | 0.56217156 |
| 90 | OXSR1 | 0.55894921 |
| 91 | MAPK12 | 0.55454778 |
| 92 | RPS6KA3 | 0.54624973 |
| 93 | CAMK1G | 0.54490370 |
| 94 | BRSK1 | 0.53825764 |
| 95 | CAMK2B | 0.53270773 |
| 96 | CDC42BPA | 0.53149248 |
| 97 | MARK2 | 0.51898660 |
| 98 | MAP2K6 | 0.48286132 |
| 99 | BMX | 0.46439932 |
| 100 | ROCK1 | 0.46372980 |
| 101 | MAPK4 | 0.46323221 |
| 102 | CCNB1 | 0.45261712 |
| 103 | MAP2K1 | 0.44955474 |
| 104 | PDK3 | 0.44627003 |
| 105 | PDK4 | 0.44627003 |
| 106 | MAPK7 | 0.43370104 |
| 107 | MAPK10 | 0.42909467 |
| 108 | TESK1 | 0.42270866 |
| 109 | DDR2 | 0.40677093 |
| 110 | IRAK2 | 0.40038848 |
| 111 | PRKG1 | 0.39472757 |
| 112 | PRKG2 | 0.37968701 |
| 113 | NEK6 | 0.37784845 |
| 114 | DYRK1A | 0.37412461 |
| 115 | FYN | 0.36757282 |
| 116 | CAMK2D | 0.36584592 |
| 117 | PRKCZ | 0.36561925 |
| 118 | FER | 0.36251710 |
| 119 | ROCK2 | 0.36109008 |
| 120 | PDGFRA | 0.34226699 |
| 121 | IRAK3 | 0.34034368 |
| 122 | PRKAA1 | 0.31054473 |
| 123 | PRKACA | 0.30702028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.14965457 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.02392005 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.61463841 |
| 4 | Long-term potentiation_Homo sapiens_hsa04720 | 2.58511326 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.51157856 |
| 6 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.38837227 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.38720682 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.36929724 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.31826094 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.15938559 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.13138294 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.10689696 |
| 13 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.09431321 |
| 14 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.08513095 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 2.00663550 |
| 16 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89851484 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.86822199 |
| 18 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.82453569 |
| 19 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.82428149 |
| 20 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.80811727 |
| 21 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.63559939 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.62630609 |
| 23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.60909921 |
| 24 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.55854846 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54556767 |
| 26 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.43760000 |
| 27 | Renin secretion_Homo sapiens_hsa04924 | 1.43543255 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.39012081 |
| 29 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.29025082 |
| 30 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28940520 |
| 31 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26843221 |
| 32 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.22099634 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.21108387 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20812250 |
| 35 | Glioma_Homo sapiens_hsa05214 | 1.19315936 |
| 36 | Cocaine addiction_Homo sapiens_hsa05030 | 1.17701451 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16014695 |
| 38 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.15429228 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.12317918 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10921006 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.10820065 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07096887 |
| 43 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96463080 |
| 44 | Melanogenesis_Homo sapiens_hsa04916 | 0.96400040 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95414340 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.93067088 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.91494486 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.91250608 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.90450775 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88495264 |
| 51 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.87504373 |
| 52 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.84868790 |
| 53 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83281551 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82341518 |
| 55 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81090341 |
| 56 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.80987987 |
| 57 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.79803715 |
| 58 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.78843973 |
| 59 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.77244637 |
| 60 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.76617660 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75547424 |
| 62 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75246049 |
| 63 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71655259 |
| 64 | Bile secretion_Homo sapiens_hsa04976 | 0.71465371 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.69550467 |
| 66 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69263079 |
| 67 | Axon guidance_Homo sapiens_hsa04360 | 0.68692734 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.66891006 |
| 69 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65609928 |
| 70 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64993482 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.64361529 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.61165454 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.60507629 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.58391747 |
| 75 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56311316 |
| 76 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55801169 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55794000 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55554530 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54942117 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.54013973 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53678926 |
| 82 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.53653606 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.52694429 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51637033 |
| 85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51620290 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48394064 |
| 87 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.44594336 |
| 88 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.44301840 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.43191523 |
| 90 | Phototransduction_Homo sapiens_hsa04744 | 0.42490148 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.42147665 |
| 92 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38490218 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.37940221 |
| 94 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.36308632 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36240064 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.35727253 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.34957830 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.34877129 |
| 99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.34726137 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.33014042 |
| 101 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.32604080 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32403767 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.32236092 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31807250 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.31207778 |
| 106 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30800851 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.29764594 |
| 108 | Tuberculosis_Homo sapiens_hsa05152 | 0.29595559 |
| 109 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29406272 |
| 110 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.29293960 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.29208453 |
| 112 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.28316691 |
| 113 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.27442270 |
| 114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.27110440 |

